NST-6179

NST-6179 · NorthSea Therapeutics B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NST-6179, covering 2024-06-24 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). [Phase 2]